Agilent Technologies Acquires Qiming-backed Biotechnology Firm ACEA Biosciences

This Data Is Locked!

This area is available only to Subscribers.

US-based Agilent Technologies has signed a definitive agreement to acquire privately-owned biotechnology company ACEA Biosciences for $250 million in cash. The acquisition will enable Agilent... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?